Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Acupuncture for Bortezomib or Thalidomide -Induced Peripheral Neuropathy in Patients With Multiple Myeloma or Lymphoma

NCT01633281 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT01633281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01633281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Acupuncture for Bortezomib or Thalidomide -Induced Peripheral Neuropathy in Patients With Multiple Myeloma or Lymphoma
Lead sponsor
Singapore General Hospital
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2012
Completion date
June 30, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy grade 2 or greater